RINTIVA
Live / Applied — Second extension granted (statement of use) (as of 08 Jul 2025)
What this means for you
Not registered yet, but its 09 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98490960
- Mark type
- Stylized text
- Filed
- 09 Apr 2024
- Published for opposition
- 10 Sept 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for prevention and treatment of cardiovascular disorders
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 19 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Aug 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2025 — SOU EXTENSION 2 GRANTED
- 08 Jul 2025 — SOU EXTENSION 2 FILED
- 08 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2025 — SOU EXTENSION 1 GRANTED
- 05 Mar 2025 — SOU EXTENSION 1 FILED
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED